During the past decade, Novant Health Cancer Institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Novant Health Cancer Institute" #1 collaborator was "Epic Sciences" with 1 trials as a collaborator, "Foundation Medicine" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Indiana University" with 1 trials as a collaborator and "Karyopharm Therapeutics Inc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Novant Health Cancer Institute" are "Breast Cancer" (1 trials), "Multiple Myeloma" (1 trials), "Myelofibrosis" (1 trials) and "Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Novant Health Cancer Institute" in a lesser frequency.

Most popular intervention types in "Novant Health Cancer Institute" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Capecitabine" (1 trials), "Dexamethasone Oral" (1 trials), "Elotuzumab" (1 trials) and "Inavolisib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Novant Health Cancer Institute" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Novant Health Cancer Institute". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Novant Health Cancer Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Novant Health Cancer Institute, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".